Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.19), $0.05 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $46.92 million versus the consensus estimate of $38.58 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.